Skip to main content

Research Repository

Advanced Search

All Outputs (410)

OBESITY - THE LAST BASTION OF PREJUDICE IN HEALTH CARE SYSTEMS? (2023)
Presentation / Conference
Rao, V., Sokhal, B., Salgaonkar, H., Ghassemi, N., Poolavadoo, Y., Khaled, S., …Cirocchi, N. (2023, August). OBESITY - THE LAST BASTION OF PREJUDICE IN HEALTH CARE SYSTEMS?. Poster presented at 26th IFSO World Congress, Naples, Italy

Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study (2023)
Presentation / Conference
Rickett, M., Kingstone, T., Gupta, V., Shiers, D., French, P., Lennox, B., & Chew-Graham, C. (2023, July). Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study. Poster presented at RCPsych International Congress 2023, Liverpool, England, UK

Aims An Early Intervention in Psychosis (EIP) service offers treatment in the community to people with a first episode of psychosis. EIP is meant to be given for three years; after this time, those who are well are discharged to their GP, while thos... Read More about Health Care Professionals’ Perspectives of Early Intervention in Psychosis Services: A Qualitative Study.

POS0999-HPR THE IMPACT OF THE COVID-19 PANDEMIC ON REFERRALS TO MUSCULOSKELETAL SERVICES FROM PRIMARY CARE AND SUBSEQUENT INCIDENCE OF INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASE: AN OBSERVATIONAL STUDY (2023)
Presentation / Conference
Bajpai, R., Burton, C., Mason, K., Bailey, J., Frisher, M., Jordan, K., …Welsh, V. (2023, May). POS0999-HPR THE IMPACT OF THE COVID-19 PANDEMIC ON REFERRALS TO MUSCULOSKELETAL SERVICES FROM PRIMARY CARE AND SUBSEQUENT INCIDENCE OF INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASE: AN OBSERVATIONAL STUDY. Poster presented at EULAR 2023 European Congress of Rheumatology, Milan, Italy

Background Inflammatory rheumatic and musculoskeletal diseases (iRMDs), including rheumatoid arthritis (RA) and juveneille inflammatory arthritsi (JIA), are common and cause a high disease burden globally. Early diagnosis of iRMDs and subsequent time... Read More about POS0999-HPR THE IMPACT OF THE COVID-19 PANDEMIC ON REFERRALS TO MUSCULOSKELETAL SERVICES FROM PRIMARY CARE AND SUBSEQUENT INCIDENCE OF INFLAMMATORY RHEUMATIC MUSCULOSKELETAL DISEASE: AN OBSERVATIONAL STUDY.

OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE (2023)
Presentation / Conference
Logan, S., Hider, S., Green, J., & Ryan, S. (2023, May). OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE. Presented at EULAR 2023 European Congress of Rheumatology, Milan, Italy

Background Guidelines recommend that people with Inflammatory Arthritis have access to tailored information when starting treatment with Methotrexate (MTX) [1]. It is not known what information people with Inflammatory Arthritis (IA) need to take MTX... Read More about OP0275-HPR ‘IT’S A LOT TO TAKE IN’: A SYSTEMATIC REVIEW OF THE INFORMATION NEEDS OF PEOPLE WITH INFLAMMATORY ARTHRITIS STARTING METHOTREXATE.

POS0508 A RANDOMISED CONTROLLED TRIAL COMPARING ANAKINRA VERSUS STEROIDS FOR THE TREATMENT OF GOUT ATTACKS IN PEOPLE WITH RENAL DISEASE (ASGARD): A FEASIBILITY STUDY (2023)
Presentation / Conference
Balasubramaniam, G., Almond, M., Harnett, P., Zhang, J., Turner, D., Scales, J., …Dasgupta, B. (2023, May). POS0508 A RANDOMISED CONTROLLED TRIAL COMPARING ANAKINRA VERSUS STEROIDS FOR THE TREATMENT OF GOUT ATTACKS IN PEOPLE WITH RENAL DISEASE (ASGARD): A FEASIBILITY STUDY. Paper presented at EULAR 2023 European Congress of Rheumatology, Milan, Italy

OP0179-HPR CHANGES IN WORK ABILITY FOLLOWING REHABILITATION (2023)
Presentation / Conference
Nilsen Skinnes, M., Moe, R. H., Johansen, T., Bruun-Hanssen, H., Dahl, K., Eid, I., …Uhlig, T. (2023, May). OP0179-HPR CHANGES IN WORK ABILITY FOLLOWING REHABILITATION. Paper presented at EULAR 2023 European Congress of Rheumatology, Milan, Italy

Living with persistent pain: A multi-method qualitative study to reducing opioids in the context of a pain review in primary care (2023)
Presentation / Conference
Woodcock, C., Cornwall, N., Harrisson, S., Knaggs, R., Pincus, T., Santar, M., …Jinks, C. (2023, May). Living with persistent pain: A multi-method qualitative study to reducing opioids in the context of a pain review in primary care. Paper presented at 56th Annual Scientific Meeting of the British Pain Society, Glasgow, Scotland, United Kingdom

Proactive review of patients taking opioid medicines for persistent pain led by pharmacists in primary care teams (PROMPPT): A feasibility study (2023)
Presentation / Conference
Ashworth, J., Cornwall, N., Harrisson, S. A., Woodcock, C., Nicholls, E., Laing, L., …Jinks, C. (2023, May). Proactive review of patients taking opioid medicines for persistent pain led by pharmacists in primary care teams (PROMPPT): A feasibility study. Presented at BPS Annual Scientific Meeting 2023, Glasgow, Scotland, UK

Quantifying the prevalence and impact of risk factors that might explain why women with type 2 diabetes have higher mortality rate than men of similar age using the retrospective data from Salford Hospital, England (2023)
Presentation / Conference
Whyte, M., Laing, I., Meza-Torres, B., Robinson, A., Fryer, A., & Heald, A. (2023, April). Quantifying the prevalence and impact of risk factors that might explain why women with type 2 diabetes have higher mortality rate than men of similar age using the retrospective data from Salford Hospital, England. Presented at Diabetes UK Professional Conference 2023, Exhibition Centre Liverpool, Liverpool, England, UK

P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise (2023)
Presentation / Conference
Paskins, Z., Moult, A., Corp, N., Bastounis, A., Davis, S., Narayanasamy, M. J., …Sahota, O. (2023, April). P082 Research priorities regarding the use of bisphosphonates for osteoporosis: a UK priority setting exercise. Poster presented at British Society for Rheumatology Annual Conference 2023, Manchester Central Convention Complex, Manchester, UK